C Lambek
Impact in
- Hematology top 2%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 17
- Chronic Myeloid Leukemia Treatments 15
- Acute Myeloid Leukemia Research 8
- Genetics 13
- Chronic Lymphocytic Leukemia Research 11
- Myeloproliferative Neoplasms: Diagnosis and Treatment 2
- Co-authors
- A Strife (18 shared papers)David Wisniewski (15 shared papers)B Clarkson (12 shared papers)Bayard D. Clarkson (4 shared papers)Zbigniew Darżynkiewicz (6 shared papers)Z Arlin (3 shared papers)Darren R. Veach (2 shared papers)Subhash C. Gulati (3 shared papers)
- Journals
- Blood (5 papers)Leukemia (2 papers)Leukemia Research (2 papers)Journal of Medicinal Chemistry (1 paper)Journal of Virology (1 paper)
- Partner nations
- United StatesSingaporeSwitzerland
In The Last Decade
C Lambek
24 papers receiving 811 citations
Peers
Comparison fields: 5 of 66
- Hematology 561
- Genetics 326
- Rheumatology 173
- Oncology 153
- Public Health, Environmental and Occupational Health 103
Countries citing papers authored by C Lambek
This map shows the geographic impact of C Lambek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Lambek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Lambek more than expected).
Fields of papers citing papers by C Lambek
This network shows the impact of papers produced by C Lambek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Lambek. The network helps show where C Lambek may publish in the future.
Co-authors
The 25 scholars most cited alongside C Lambek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Characterization of potent inhibitors of the Bcr-Abl and the c-kit receptor tyrosine kinases. | 2002 | 135 |
| 2 | 1982 | 128 | |
| 3 | 2003 | 84 | |
| 4 | 1997 | 59 | |
| 5 | Discordant maturation as the primary biological defect in chronic myelogenous leukemia. | 1988 | 56 |
| 6 | 1992 | 47 | |
| 7 | 1978 | 43 | |
| 8 | 2007 | 32 | |
| 9 | 2011 | 30 | |
| 10 | Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination. | 1991 | 30 |
| 11 | 1992 | 29 | |
| 12 | A 62-kilodalton tyrosine phosphoprotein constitutively present in primary chronic phase chronic myelogenous leukemia enriched lineage negative blast populations. | 1994 | 29 |
| 13 | 1983 | 24 | |
| 14 | The effects of transforming growth factor beta 3 on the growth of highly enriched hematopoietic progenitor cells derived from normal human bone marrow and peripheral blood. | 1991 | 22 |
| 15 | Characterization of lineage-negative blast subpopulations derived from normal and chronic myelogenous leukemia bone marrows and determination of their responsiveness to human c-kit ligand. | 1993 | 19 |
| 16 | 1983 | 16 | |
| 17 | Direct evidence that Bcr-Abl tyrosine kinase activity disrupts normal synergistic interactions between Kit ligand and cytokines in primary primitive progenitor cells. | 2003 | 12 |
| 18 | Enrichment of hematopoietic progenitor cells (CFUC and BFUE) from human peripheral blood. | 1982 | 11 |
| 19 | 1993 | 10 | |
| 20 | 2000 | 8 |
About C Lambek
C Lambek is a scholar working on Hematology, Genetics, Oncology, Molecular Biology and Rheumatology, having authored 24 papers that have together received 848 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (15 papers), Chronic Lymphocytic Leukemia Research (11 papers), Acute Myeloid Leukemia Research (8 papers), Glycosylation and Glycoproteins Research (3 papers), Eosinophilic Disorders and Syndromes (3 papers), Cancer Genomics and Diagnostics (2 papers), Cancer-related Molecular Pathways (2 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers). The work is most often cited by research in Hematology (561 citations), Genetics (326 citations), Rheumatology (173 citations), Oncology (153 citations) and Public Health, Environmental and Occupational Health (103 citations). C Lambek has collaborated with scholars based in United States, Singapore and Switzerland. Frequent co-authors include A Strife, David Wisniewski, B Clarkson, Bayard D. Clarkson, Zbigniew Darżynkiewicz, Z Arlin, Darren R. Veach, Subhash C. Gulati, Nick Carpino and Dorothea L. Sawicki. Their work appears in journals such as Blood, Leukemia, Leukemia Research, Journal of Medicinal Chemistry and Journal of Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.